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Abstract
Maternal obesity results in a number of obstetrical and fetal complications with both immediate and long-term
consequences. The increased prevalence of obesity has resulted in increasing numbers of women of reproductive age in this
high-risk group. Since many of these obese women have been subjected to hypercaloric diets from early childhood we have
developed a rodent model of life-long maternal obesity to more clearly understand the mechanisms that contribute to
adverse pregnancy outcomes in obese women. Female Sprague Dawley rats were fed a control diet (CON - 16% of calories
from fat) or high fat diet (HF - 45% of calories from fat) from 3 to 19 weeks of age. Prior to pregnancy HF-fed dams exhibited
significant increases in body fat, serum leptin and triglycerides. A subset of dams was sacrificed at gestational day 15 to
evaluate fetal and placental development. The remaining animals were allowed to deliver normally. HF-fed dams exhibited a
more than 3-fold increase in fetal death and decreased neonatal survival. These outcomes were associated with altered
vascular development in the placenta, as well as increased hypoxia in the labyrinth. We propose that the altered placental
vasculature may result in reduced oxygenation of the fetal tissues contributing to premature demise and poor neonatal
survival.
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Introduction
Data from the Centre for Disease Control indicate that in 2008,
almost 20% of children between ages 6–11 were considered obese,
and many of the females in this group are likely to remain obese
through their childbearing years [1]. In fact, epidemiological
studies report that 15–20% of women of reproductive age in
Canada, US, Australia and the UK are now clinically obese
(BMI.30 kg/m
2) [2–4]. With obesity rates on the rise, it is clear
that the consequences of life-long obesity on pregnancy outcomes
need to be addressed. There is compelling evidence that obese
women are at increased risk for many pregnancy-related
complications to their own health, such as gestational diabetes
and preeclampsia [5–7]. In addition to maternal health issues,
there is also a considerable increase in the risk of fetal
complications such as spontaneous abortions, fetal asphyxia, and
stillbirth [8], as well as increased risk of delivery of both small for
gestational age (SGA) and large for gestational age (LGA) babies
[2,9,10]. Pre-gravid obesity also contributes to reduced fertility in
women [6,11,12]. This may be due to disruptions in oocyte
function [13] or a chronic state of inflammation associated with
obesity [14], which may contribute to impaired implantation of
the blastocyst [15].
While the mechanisms behind the obesity-mediated reduction
in fecundity are not clearly understood, current speculation
suggests that altered levels of cytokines and adipokines, as well
as hormones such as insulin, may impact ovulation and
implantation (reviewed in [16]). Maternal obesity is also associated
with a number of metabolic disturbances such as insulin resistance,
elevated serum triglycerides, and increased blood pressure
(reviewed in [17]). In addition to these systemic effects, obesity
has also been associated with tissue specific changes in mitochon-
drial function and elevated production of reactive oxygen species
(ROS) leading to increased oxidative stress [18,19].
Some of these changes associated with maternal obesity may
lead to alterations in placental development or function. Of critical
importance to proper placental development is the establishment
of the vascular architecture between maternal and fetal circulatory
systems. Functional deficiencies at this interface can contribute to
intrauterine growth restriction (IUGR) and pre-eclampsia (re-
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33370viewed in [20]), as well as a significant increase in premature fetal
demise [6,21,22]. While previous epidemiological studies have
linked increased BMI with placental dysfunction and adverse
obstetrical outcomes [2,23] the mechanisms for such associations
have not been fully elucidated.
The majority of animal models that attempt to address the
consequences of maternal obesity focus on postnatal outcomes
[24] or subject the dams to short-term high fat (HF) diets just prior
to pregnancy or during gestation [25,26]. This has resulted in a
relative paucity of data regarding the consequences of long-term
maternal obesity on placental function and fetal development. We
have developed a rodent model which addresses the consequences
of life-long obesity on the development of the placenta. Our model
suggests that a life-long high fat diet results in altered
vascularization of the placenta and this has adverse consequences
for fetal survival. We observe increased numbers of stillbirths and
reduced weight at birth, as well as reduced neonatal survival.
These poor fetal and neonatal outcomes may be due to increased
placental hypoxia and a trend towards increased oxidative stress as
a consequence of altered development of the placental vasculature.
Results
HF-diet results in increases in the biomarkers associated
with obesity
HF-fed dams were 22% heavier by 19 weeks of age (Figure S1)
and had 3-fold greater levels of serum leptin compared CON-fed
dams (Table 1). To assess the body fat composition in dams prior
to pregnancy, CT scans (n=7 in each group) were performed at
19 weeks of age (Figures 1A and 1B). The total body fat content for
the area between the bottom of the lungs and the top of the
sacroiliac joint was approximately 7 fold higher in the HF-fed
dams as compared to the CON-fed dams (Figure 1C). In addition,
abdominal fat pad weight during pregnancy (GD15) was found to
be 2.5-fold greater in HF-fed animals (10.0860.49% vs.
4.2460.25% of total body weight; Figure 1D).
In order to determine if increased body weight prior to
pregnancy was associated with pre-pregnancy dysglycemia, we
determined fasting glucose, insulin and HOMA-IR levels at 17
weeks of age (Table 1). Fasted glucose levels were significantly
elevated in HF-fed dams prior to mating (CON: 4.960.3 mmol/L
vs. HF: 5.760.2 mmol/L, p,0.05); however, fasted insulin levels
and HOMA-IR were not significantly different. Interestingly,
while the oral glucose tolerance test in these animals did not
exhibit a significant difference between the two groups of dams,
the insulin tolerance test demonstrated that HF-fed dams had a
significantly greater area under the curve (AUC; Table 1)
compared to CON-fed dams.
Prior to mating, HF-fed dams had significantly higher levels of
fasting serum triglycerides (1.8 fold higher than CON-fed dams).
Leptin levels were 3.5 fold greater in the HF-fed dams as
compared to the CON-fed dams. Circulating non-esterified fatty
acids (NEFA) and cholesterol levels were not different between the
two groups.
Elevated gestational blood pressure in HF-fed dams
HF-fed dams had significantly higher systolic, diastolic and
mean arterial pressure (MAP) at GD15 relative to normal weight
dams (Figure 2). The difference in the MAP between HF-fed and
CON-fed animals, was 21 mmHg (13862.8 vs 11761.7 mmHg).
While the HF-dams did exhibit a higher blood pressure prior to
pregnancy they also demonstrated a greater increase in their
blood pressure over the course of their pregnancy as compared
to the CON-fed dams (Figure S2). The greatest degree of
difference between the two groups was evident between GD15
and GD20.
Life-long HF-diet affects obstetrical outcomes
A HF-diet for 4 months prior to mating impacted a number of
obstetrical and fetal outcomes (Table 2). Time to copulation was
significantly longer for HF-fed dams relative to CON-fed dams
(3.8060.41 vs. 2.5960.39 days for CON-fed dams). Furthermore,
the mating success for HF-fed dams was reduced by 32.4%, while
the fertility index for this group was 22.1% lower. A significantly
higher proportion of the offspring of HF-dams were small for
gestational age (CON: 0.7% - 3/383 pups vs. HF: 4.7% -11/234
total pups). Most interestingly, there was a dramatic shift in the
male/female ratio for HF-fed dams. The sex ratio (M/F) for
CON-fed dams was 1.1960.14; in contrast, the ratio for HF-fed
dams was 0.6760.11 (p=0.008) indicating that significantly fewer
males were born to this group of mothers.
Maternal obesity leads to compromised fetal growth and
poor neonatal health
Life-long maternal obesity impacts fetal growth and develop-
ment. Obese dams not only had 30% fewer pups per litter
(Figure 3B) but individual pup weights, both males and females,
were reduced by 12% (Figure 3A). Even more striking was the
significant increase in the number of HF-fed dams that gave birth
to stillborn pups. 45% of the HF-fed dams compared to only 10%
of CON-fed dams delivered stillborn pups (Figure 3C). Further-
more, the live pups born to HF-fed dams had reduced survival to
post-natal day 4, an indicator of poor neonatal health [27].
Indeed, only 25% of the pups born to HF-fed dams survived past
PND4 (Figure 3D).
In utero fetal development was also affected by maternal obesity.
Evidence of premature fetal demise in the HF-fed dams was
indicated by an almost 3-fold increase in the number of uterine
absorption sites (Figure 3F). Furthermore, the fetal to placental
weight ratio also exhibited a 12% reduction in this group of dams
(p,0.05) (Figure 3E).
The placenta of HF-fed dams are characterized by altered
vascular development
Maternal obesity affected blood vessel density and maturity
(Figure 4 and 5) in the labyrinth. There was an almost 2 fold
Table 1. Pre-pregnancy metabolic parameters of fasted
dams.
Outcome measure CON-fed Dams HF-fed Dams P
Fasting Glucose (mmol/L) 4.960.3 5.760.2 0.03*
Fasting Insulin (ng/mL) 1.060.2 1.260.3 0.64
Glucose AUC 290.1647.1 247.7655.2 0.56
Insulin AUC 15064.4 16767.0 0.01*
HOMA-IR 0.1160.02 0.1160.05 0.79
Triglyceride (mg/dL) 72.5613.9 131.8619.0 0.02*
NEFA(mmol/L) 0.560.1 0.660.1 0.41
Total Cholesterol (mg/dL) 110.267.3 106.067.8 0.34
Leptin 3.5560.51 12.7261.69 0.0001*
Values are mean 6 SEM,
*significantly different between CON-fed and HF-fed dams.
doi:10.1371/journal.pone.0033370.t001
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the placenta of HF-fed dams compared to controls (Figure 4C).
Accordingly, the blood vessel density within the placenta (number
of CD31-positive blood vessels per field) was higher (Figure 4D).
However, there was a 30% decrease in the number of blood vessels
that stained positive for smooth muscle actin (SMA), a marker
expressed by vascular smooth muscle cells and found in mature
blood vessels (Figures 5).
The placentas of HF-fed dams are characterized by
reduced tissue oxygenation
The levels of carbonic anhydrase within the placenta were
evaluated as an indicator of tissue hypoxia [28]. Carbonic
anhydrase-immunopositive tissue in HF placenta was increased
by 47% over CON placenta (Figure 6A–C).
Since hypoxia is known to increase oxidative damage in the
placenta [29] we assessed whether there was a change in the level
of systemic oxidative damage in obese pregnant dams by
quantifying urinary 8-hydroxy- 2-deoxyguanosine (8OH-2-dG).
This is a well characterized marker of oxidative damage, and its
increase in obesity has been reported in both humans [30] and
rodents [31]; therefore we carried out a one-tailed Students T-test
with respect to the significance of this data. Urinary 8OH-2-dG
levels in the HF-fed animals were 25% higher relative to the
CON-fed dams; however this did not reach statistical significance
(p,0.1) (Figure 7). There was also an increase in the mean levels of
4-HNE (p,0.1) in whole placental homogenates of GD15 HF-fed
dams (Figure 8A and B). Interestingly, a mitochondrially enriched
fraction isolated from the placentas of HF-fed also exhibited
increases in the levels of protein carbonyls, a marker of oxidative
protein damage (Figure 8C and D; p,0.1). While neither of these
markers of oxidative damage were statistically different in the
placenta of CON-fed vs HF-fed animals, the mean levels are
consistently higher in the HF-fed dams.
Discussion
The effects of maternal obesity on pregnancy outcomes in
humans are well documented. Despite the plethora of epidemi-
Figure 1. CT analysis demonstrates that a HF-diet leads to increased subcutaneous and abdominal fat. Fasted rats were anesthetized
and subjected to CT scanning. A. Representative CT-scan of a CON-fed dam; B. Representative CT-scan of a HF-fed dam. Adipose tissue is
characterized by a lower intensity signal (darker regions on the image). The area occupied by the abdominal fat (AB) and subcutaneous fat (SQ) are
indicated; scale bar=1 cm. C. Adipose tissue absorption in the area between the bottom of the lungs and the top of the sacroiliac joint was
calculated with Amira software using attenuation thresholds of 2150 to 2400 Hounsfield units. The values represent mean 6 SEM. * p,0.01; n=7 in
each group. D. The mass of total abdominal adipose tissue during pregnancy (GD15) was also quantified and expressed as a percentage of body
weight. The total pool includes gonadal, retroperitoneal and mesenteric fat. Values represent mean 6 SEM; *p,0.01, n$18 in each group.
doi:10.1371/journal.pone.0033370.g001
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Obstetrical Outcome CON-fed Dams HF-Fed Dams P






Mating success (%) 100 67.6 0.004*
Fertility Index (%) 73.8 51.7 0.03*
Live Birth Index 98.960.6 87.764.9 0.03*
LGA 11/383 0/234 0.003*
SGA 3/383 11/234 0.009*
Sex Ratio (M/F) 1.1960.14 0.6760.11 0.008*
Values are mean 6 SEM,
*significantly different between CON-fed and HF-fed dams.
doi:10.1371/journal.pone.0033370.t002
Figure 2. Arterial Blood Pressure in elevated in obese dams at
GD 15. Blood pressure was determined at GD15 using tail cuffs.
Animals were gently restrained in cages warmed to 37uC using a
heating pad. The hatched bars represent CON-fed animals, while the
solid black bars represent HF-fed animals. Values are mean 6 SEM;
*p,0.05, n$23 in each group. The animals underwent 5 acclimatization
cycles and 20 measurement cycles. The reported values are the mean of
these 20 cycles.
doi:10.1371/journal.pone.0033370.g002
Figure 3. Neonatal health outcomes for pups born to CON or HF-fed dams. A. The body weight of offspring of CON-fed (hatched bar) or HF-
fed (solid black bar) dams on postnatal day 1 (PND1). B. The average number of pups per litter born to CON-fed or HF-fed dams. C. The percentage of
CON-fed or HF-fed dams giving birth to at least one stillborn pup. D. The percentage of the total number of live pups in the litter that survived to
PND4. E. The fetal/placental weight ratio was calculated for CON-fed and HF-fed dams. F. The average number of resorption sites for CON-fed and HF-
fed dams at GD15. Values represent mean 6 SEM;
*p,0.05; n$12 dams per group.
doi:10.1371/journal.pone.0033370.g003
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the mechanistic understanding of the cellular signaling that
mediates poor health outcomes for both mother and fetus are
far from clear. These adverse outcomes include metabolic
complications in the offspring [32], obstetrical complications in
the mother [9,21] and abnormal fetal growth [22,33]. The lack of
a mechanistic understanding of these processes may be due, in
part, to the difficulty of developing animal models that emulate all
the complications of obesity during pregnancy in humans. The
majority of rodent models designed to address the consequences of
maternal obesity have been focused on understanding metabolic
reprogramming in offspring and have not focused on factors
responsible for premature fetal demise and poor neonatal health.
Our rodent model of life-long maternal obesity is characterized
by the well accepted hallmarks associated with obesity such as
elevated serum leptin and triglycerides and increased body fat. An
evaluation of glucose homeostasis prior to pregnancy demonstrat-
ed that the HF-fed dams had a small but significant increase in
their fasting glucose levels and were insulin resistant (i.e., had an
increased area under the curve following an insulin challenge).
This is to be expected with such obese animals. However the
results of the glucose tolerance test did not prove to be significantly
different between the groups. This suggests that the pancreas has
been able to modulate insulin secretion to maintain glucose
homeostasis and these animals have not yet developed overt type 2
diabetes mellitus. Taken together the data suggest that there is
partial loss of glycemic control in the HF-fed animals which may
become aggravated during pregnancy. We did not conduct
OGTT measurements during pregnancy due to the possibility
compromising fetal health.
The model also demonstrates many of the fetal and maternal
complications seen in human pregnancies associated with obesity;
increased blood pressure during pregnancy, reduced fetal growth,
and increased fetal/neonatal demise [22,34]. In addition to the
parallels in fetal outcomes, we also observed obstetrical compli-
cations associated with obesity in reproductive age women such as
reduced fertility [6]. Interestingly, the majority of epidemiological
studies report that obese women are at significantly greater risk for
delivering large for gestational age (LGA) babies, yet there is also
an elevated risk for small for gestational age (SGA) babies which
has also been noted in humans, primates and rodents [10,34,35].
An evaluation of singleton pregnancies between 1978–1997 in
Missouri (over 310,000 pregnancies) found that SGA babies born
to obese mothers were at significantly greater risk for neonatal
death [36] compared to LGA babies born to this group.
Furthermore, the risk of premature death for these neonates
increased with degree of their mother’s obesity [24,26]. Since the
mechanisms for such phenomenon are not well understood it
underscores the importance for developing an animal model for
elucidating the pathways leading to premature fetal demise and
poor neonatal health.
Reduced fetal growth and premature fetal demise, as a
consequence of obesity during pregnancy, may implicate placental
dysfunction. Similar outcomes have been connected with placental
dysfunction in preeclampsia and IUGR [38]. While higher rates of
preeclampsia are associated with obesity [39], it has been argued
that this is a uniquely human condition and may not be accurately
emulated in rodent models [40]. Two recent studies have also
reported poor fetal growth in association with maternal obesity,
but have not evaluated premature fetal demise in their respective
Figure 4. The labyrinth layers of placentas from HF-fed dams exhibit increased expression of endothelial cell markers at GD15.
Representative images, acquired at 1006magnification, of GD15 placenta from CON-fed (A) and HF-fed dams (B) immunostained with CD31 antibody
are shown. Scale bar=50 mm; the labyrinth (L) and junctional zone (JZ) are indicated for reference. Four distinct regions from each histological
section were quantified and averaged in determining percent immunopositive area. Images from an individual dam represent a single statistical unit.
C. The percentage of area immunopositive for CD31 in the labyrinth of GD15 placenta based on the analysis of cross sections from CON-fed and HF-
fed dams sacrificed at GD15. D. The number of blood vessels per field for CON-fed or HF-fed dams at GD15. All values mean 6 SEM,
*p,0.05; n=5
dams for each group.
doi:10.1371/journal.pone.0033370.g004
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high-fat diet in Japanese macaques resulted in fetal growth
retardation. Similarly, in a rodent model, Akyol et al. showed that
Sprague-Dawley dams fed a cafeteria diet prior to and during
pregnancy had lower fetal and placental weights, as well as a lower
fetal:placental weight ratio at GD20 of pregnancy [35]. In
agreement with these observations, the birth weight of the pups
from our cohort of HF-fed dams was reduced by 12%, and we also
observed a decreased fetal:placental weight ratio at GD15.
However, this growth retardation was not as profound as has
been reported in rodent models of chemically induced pre-
eclampsia (more than a 30% decrease in pup birth weight) [38].
The current model of maternal obesity is also characterized by a
significant increase in the number of HF-fed dams delivering
stillborn pups, as well as an increase in the number of fetal
resorption sites; further evidence of premature uterine demise.
Epidemiological data suggest that the mechanisms behind a large
percentage of reported stillbirths are not well understood [8]. Our
rodent model clearly points to a role for maternal obesity-
associated placental dysfunction in increasing the risk of stillbirths
and supports the existing epidemiological data [12].
In humans, epidemiological data has been used to suggest a
correlation between metabolic syndrome and placental dysfunction
[23]. It is important to note that while the temporal relationships in
placentation differ between rodents and humans, the early processes
leading to the establishment of the maternal-fetal interface are
common, making rats a good model for placental studies [37].
In order to understand why the fetuses of HF-fed dams failed to
thrive, we analyzed the histomorphology of the placenta at mid-
gestation (GD15). We observed an increase in CD31 staining in
the labyrinth of placentas from HF-fed dams indicating the
presence of greater numbers of blood vessels, an observation
supported by recent data which has demonstrated that vascular-
ization is also dysregulated in the placental cotyledons of the obese
ewe [35]. Interestingly, the increase in blood vessel density,
observed in our model, was inversely proportional to the staining
with SMA, an indicator of blood vessel maturity [42]. A reduction
in the presence of SMA staining surrounding endothelial cells in
the labyrinth has been associated with increased gestational blood
pressure and reduced fetal growth in a mouse model of
preeclampsia [43].
Together this suggests that placenta of HF-fed dams may have
significant deficits in the processes involved with blood vessel
maturation. The poor development of the placental vasculature in
the placenta of obese dams may result in reduced blood flow to the
placenta, an observation which is consistent with the evidence of
hypoxia in the placenta of HF-fed dams. In humans, changes in
vascularization and hypoxia in the placenta are associated with
several disorders of pregnancy, including IUGR, SGA fetuses and
preeclampsia [44]. Hypoxia is known to be a signal for the
production of VEGF [45] which may trigger increased angiogen-
esis and would be consistent with the increased CD31 staining
observed in the placenta’s of our HF-fed dams.
Hypoxia is also associated with increased oxidative stress [29]
which in turn can result in significant placental pathology [46].
Furthermore, systemic increases in the markers of oxidative stress
have also been reported in obese humans [30] as well as rodents
[31]. In general, oxidative stress results from an imbalance
Figure 5. The labyrinth layers of placentas from HF-fed dams exhibit fewer SMA positive blood vessels at GD15. Representative
images, acquired at 2006magnification, of GD 15 placenta from CON-fed (A) and HF-fed dams (B) immunostained with an antibody to SMA are
shown. The SMA positive area within the labyrinth (L) of each group of animals was quantified. C. The average number of vessels per field of view
staining positive for smooth muscle actin (SMA) in placentas from CON-fed and HF-fed dams. D. All values mean 6 SEM;
*p,0.05, n=5 dams for each
group.
doi:10.1371/journal.pone.0033370.g005
Obesity Affects the Development of the Placental Vasculature
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33370between increased cellular ROS production and cellular antiox-
idant defenses. If ROS production overwhelms cellular defenses
then this can result in either increased cellular damage or adaptive
changes mediated by free radical signaling [47]. We therefore
assessed the level of oxidative damage in our HF-dams by using
several markers of systemic as well as tissue specific oxidative
damage. While our HF-fed dams did not exhibit a statistically
significant increase in systemic oxidative damage, the mean level
of urinary 8OH-2-dG (a marker of oxidative damage to DNA),
was higher in this group. In addition to being associated with
obesity, increases in 8OH-2-dG in maternal mid-gestational urine
has been associated with reduced fetal weight at birth in humans
[48]. Oxidative stress results from the production of superoxide
radicals from a number of cellular sources, including mitochon-
dria, which ultimately contribute to the formation lipid peroxides,
protein carbonyls, or 8OH-2-dG [47,49]. These represent markers
of lipid, protein and DNA damage respectively. The consequence
of such increases in ROS are dictated by the reactivity and lifetime
of the reactive species (reviewed in [50]). Interestingly, recent work
by Myatt and colleagues suggests that the majority of the oxygen
free radicals formed in the pre-eclamptic placenta is converted to
peroxynitrite and this results in an increase in protein nitration and
perhaps a decrease in overall markers of oxidative damage [51].
Our attempts to compare the level of nitrotyrosine modification in
the GD15 placental homogenates of CON-fed vs. HF-fed dams
demonstrated that while there was an increase in the mean of the
level of protein residues modified by nitrotyrosine the values did
not reach statistical significance (Figure S3). We also observed a
small increase in the mean levels of lipid damage (4-hydroxy-2-
noneal) in the placenta of HF-fed dams (p,0.1). We therefore
examined whether oxidative damage may be more evident in
isolated mitochondria because they are considered to be one of the
primary producers of cellular superoxide. Due to the limited
diffusion distance of superoxide, the probability of damage
proximal to the site of production may be greater. We demonstrate
in this study that the mitochondria isolated from whole placenta of
HF-fed dams also exhibited increased mean levels of protein
damage (protein carbonyls) but these did not reach statistical
significance. While we cannot conclude that there is an increase in
the level of oxidative stress in the placenta of obese dams, it is
interesting to note that three separate markers of oxidative damage
all exhibited increased mean levels in the placenta of obese dams.
Furthermore, we cannot exclude the absence of oxidative stress
because of the possibility that diet may have resulted in increased
expression of ROS defense proteins which may attenuate the level
of damaging radical species.
The altered vascular development and associated hypoxia in the
placentas of HF-fed dams may contribute to poor fetal growth and
neonatal survival. Our model demonstrated that the offspring of
HF-fed dams exhibited increased neonatal death. A link between
reduced fetal growth in utero and poor neonatal health has been
suggested based on the observation that SGA babies born to obese
women exhibit reduced post-natal survival [36]. However,
neonatal demise may be the result of a number of perinatal, as
well as postnatal factors. For example, epidemiological studies
have pinpointed maternal obesity as a predictor of delayed onset of
lactation as well as a reduced intention to breastfeed [52,53].
Recent work by Bautista et al. suggest that maternal obesity, in a
rat model, results in reduced breast milk production higher fat and
leptin content [54]. Our current experimental design does not
Figure 6. The labyrinth layers of placentas from HF-fed dams exhibit increased levels of carbonic anhydrase staining at GD15.
Representative images, acquired at 2006magnification, of GD 15 placenta from CON-fed (A) and HF-fed dams (B) immunostained with an antibody
to carbonic anhydrase are shown. C. The average staining intensity in placentas from CON-fed and HF-fed dams was calculated. All values mean 6
SEM,
*p,0.05; n=5 dams for each group.
doi:10.1371/journal.pone.0033370.g006
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factors contribute to the early demise of the neonates.
Taken together our model of life-long maternal obesity in
rodents exhibits many of characteristics demonstrated clinically in
obese humans including premature fetal demise and reduced fetal
growth. Our data is consistent with the view that excess adiposity
during pregnancy alters the development of the placental
vasculature and this reduces tissue oxygenation. Using examples
of undernutrition during pregnancy, it been suggested that the
fetus adapts to increased uterine stress and hypoxia by sparing the
growth of the brain and reducing body growth [55,56]. It is
possible that this increased uterine stress, as a result of maternal
obesity, facilitates the development of defects in the pathways
responsible for the proper development of the placental vascula-
ture. In fact, it has been suggested that failure to remodel the spiral
arteries may be associated with increased oxidative stress and
pregnancy failure in humans [57]. It will therefore be important to
delineate the mechanisms by which obesity can affect development
of placental vasculature. The elucidation of these pathways will
contribute to understanding how maternal obesity affects poor
fetal development and premature death.
Materials and Methods
Animal protocol and sampling of histological
preparations
All animal procedures for this study were approved by the
McMaster University Animal Research Ethics Board (Animal
Utilization Protocol 07-07-40) in accordance with the guidelines of
the Canadian Council of Animal Care. Female Sprague-Dawley
rats, aged 21 days (84–100 g), were purchased from Charles River
Laboratories (Willmington, MA). Rats were maintained under
controlled lighting (12 hr light – dark cycle) and temperature
(22uC) with ad libitum access to food and water. Dams were
randomly assigned to receive either standard rat chow (CON)
(16% kcal fat, 3.82 kcal/g; Harlan Teklad, Madison, WI) or a high
fat (HF) diet (45% kcal fat, 4.70 kcal/g; Research Diets, New
Brunswick, NJ) (Table - S1). Body weights of each dam were
monitored biweekly. Dams were maintained on their respective
diets for 16 weeks before being mated with age-matched
Sprague-Dawley males fed the CON diet. Copulation was
confirmed by the presence of sperm in a vaginal flush; the day
of copulation was designated gestational day 0. A subset of dams
(CON n=20, HF n=18) underwent laparotomy at GD15,
exposing the uterine cavity with the fetuses. Resorption sites
were counted and each fetus and its corresponding placenta
were separated and weighed. Placental tissue samples were
snap-frozen in liquid nitrogen storage or placed in 10% neutral
buffered formalin for immunohistochemical analysis. The remain-
ing dams (CON n=25, HF n=20) were allowed to give birth
normally.
Measures of obstetrical outcomes
A number of obstetrical outcomes including average time to
copulation (number of days cohabited to achieve a sperm positive
vaginal flush), mating success (sperm positive dams/total number
of cohabiting pairs), fertility index (number of confirmed
pregnancies/sperm positive dams), live birth index (number of
live pups/total number of pups for each litter), sex ratio (M:F) and
litter size were determined. We also determined the number of
pups that were either large for gestational age (LGA; birth weight
greater than 2 standard deviations above the average birth weight
of control pups) or small for gestational age (SGA; birthweight less
than 2 standard deviations below the average birthweight of
control pups).
CT Scanning and Analysis
To determine the amount of visceral and subcutaneous fat
accumulation in the abdominal area, a subset of the animals in
each group were fasted for 16 hr at 19 weeks of age (CON=7 and
HF=7) and CT scanning was carried out using the X-SPECT
small animal imaging system (Gamma Medica, Northridge, CA,
USA). The midsection of the rat was scanned and the area
between the bottom of the lungs and the top of the sacroiliac joint
was selected for fat quantification. This area contained approx-
imately 100 slices, each 0.5 mm apart. Densitometric quantifica-
tion of fat was carried out using Amira software with attenuation
thresholds of 2450 to 2150 Hounsfield units (HU) to select for fat
tissue. Air bubbles in the intestines were first removed from the
image, and the total fat (subcutaneous+abdominal) was then
quantified by integrating all voxels (a 3-dimensional pixel) between
2450 and 2150 HU.
Blood pressure analysis
Blood pressure measurements were taken prior to pregnancy as
well as at GD15 and GD20. The animals were placed in mouse
cages, warmed to 37uC, and wrapped in a surgical towel to
minimize stress due to forcible restraint. Two cuffs (occlusion cuff
and volume pressure recording cuff) were attached to their tails.
Mean arterial blood pressures, diastolic and systolic blood pressure
and heart rate readings were measured for each animal (Coda6,
Kent Scientific, Torrington, CT). The animals underwent 5
Figure 7. 8-hydroxy 2-deoxyguanosine, a marker of systemic
oxidative damage, is not significantly increased in the HF-
dams. Levels of 8-OH-2-dG were quantified in urine collected from
GD15 CON-fed and HF-fed dams at sacrifice using a competitive EIA kit.
8-OH2-dG was normalized to the concentration of creatinine in urine.
All values mean 6 SEM, n=15 for CON and n=10 for HF-fed dams.
{p,0.1 by one tailed Students T-test.
doi:10.1371/journal.pone.0033370.g007
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Maternal metabolic parameters: Pre-pregnancy measures
Glucose tolerance was determined in CON- and HF-fed dams
prior to pregnancy following a 16 hr fast. Animals were given 2 g/
kg body weight D-glucose by gavage. Blood was sampled from the
saphenous vein at 0, 30, 60 and 120 min. Insulin tolerance tests
were carried out following a 16 hr fast. Animals were injected with
1 U/kg of human insulin (Novolin ge, Novo Nordisk, Bagsvared,
Denmark) and blood was sampled from the saphenous vein at 0,
30, 60, 120 min. The fasting blood glucose (Pointe Scientific,
Canton, MI), serum triglycerides (Pointe Scientific Inc, Canton,
MI), non-esterified fatty acids (NEFA; Roche Diagnostics,
Indianapolis, IN) and total cholesterol (Pointe Scientific Inc,
Canton, MI) were quantified using colorimetric assays according
to manufacturers’ instructions. Insulin was measured using a high-
sensitivity rat insulin ELISA (Crystal Chem Inc, Downers Grove,
IL) while leptin was quantified using a direct rat leptin ELISA kit
(Crystal Chem Inc, Downers Grove, IL).
Calculation of HOMA-IR
The homeostatic model of insulin resistance (HOMA-IR) was
calculated [58] from fasting insulin and glucose concentrations
Figure 8. Markers of tissue specific oxidative damage are not significantly increased in placentas from HF-fed dams at GD15. A.
10 mg of total whole placental homogenate was separated on a 12.5% SDS-PAGE and subjected to Western blot analysis. The average content of 4-
HNE was normalized to total protein (using Ponceau-S staining) in CON (hatched bars) or HF-fed (solid black bars) dams. B. Representative lanes
containing 10 mg placental homogenates, developed using the 4-HNE monoclonal antibody. C. The relative content of protein carbonyls was
quantified using a polyclonal antibody directed towards 2,4-dinitrophenylhydrazine (DNPH). This quantification was carried out using 5 mgo f
placental homogenate enriched for mitochondria. D. Representative lanes containing 5 mg of protein, enriched for mitochondria, prepared from CON
or HF-fed dam placenta were separated on a 12.5% SDS-PAGE and developed using the anti DNPH polyclonal antibody. Values represent mean 6
SEM;
{p,0.10, n=6 per group.
doi:10.1371/journal.pone.0033370.g008
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insulin (mU/L)/22.5.
Immunohistochemistry
Formalin-fixed whole placenta were embedded and sectioned at
a thickness of 5 mm. Sections were de-paraffinized in xylene and
rehydrated in graded alcohol solutions. Immunohistochemistry
(IHC) was performed to determine localization and expression of
CD31 (an endothelial cell marker), smooth muscle actin (SMA, a
marker of blood vessel maturity), and carbonic anhydrase (CA, a
marker of tissue hypoxia). Endogenous peroxidase activity was
inhibited using 1% hydrogen peroxide for 10 minutes at RT.
Antigen retrieval was achieved by immersing slides in 10 mM
citrate buffer at 90uC for 12 minutes. Tissues were blocked using
5% BSA for 10 minutes at RT. Tissues were incubated with anti-
CD31 (BD Biosciences Pharmingen, San Diego, CA) or rabbit
anti-carbonic anhydrase-IX (1:500 dilution; Abcam, Cambridge
MA) overnight at 4uC in a humidified chamber. The following
day, sections were incubated with anti-mouse (CD31) biotinylated
secondary antibody (Sigma-Aldrich Canada Ltd., Oakville, ON)
or biotinylated goat anti-rabbit (CA) (1:500 dilution; Vector Labs,
Burlingame CA) for 2 hours at RT. Tissues were then exposed to
ExtrAvidinH (Sigma-Aldrich Canada Ltd., Oakville, ON) for
1 hour at RT and antibodies were visualized using DAB (Sigma-
Aldrich Canada Ltd., Oakville, ON). Tissue was counterstained
with Carazzi’s Hematoxylin, dehydrated and mounted on
coverslips. Slides were imaged using brightfield microscopy.
Blood vessel density and maturity were quantified using the
Metamorph integrated morphometry software (Molecular Devices,
Downingtown, PA). For the determination of vessel density, a
minimum of 4 fields of view per tissue section were used. We
quantified sections from 5 individual animals per group. All analysis
was carried out in a blinded fashion. Mature blood vessels were
characterized as having pericyte coverage (SMA positive vessels)
[43]. To quantify the level of tissue hypoxia, the percentage of tissue
immunopositive for carbonic anhydrase was measured.
Western blotting
Whole placental tissue samples were homogenized in a 1:25
ratio of tissue to homogenization buffer (5 mM HEPES, pH 7.2,
100 mM KCl, 70 mM sucrose, 220 mM mannitol, 1 mM EGTA)
with protease inhibitor cocktail tablets (Roche diagnostics,
Indianapolis IN). Levels of 4-hydroxynonenal (4-HNE) and
nitrotyrosine were quantified using Western blotting, as previously
described [59]. Briefly, 20 mg of placental homogenate was
separated on a 12.5% SDS-PAGE gel and transferred to
nitrocellulose membranes. Membranes were blocked in 5% bovine
serum albumin (BSA; Roche, Indianapolis, IN) in Tris buffered
saline (TBST: 137 mM NaCl, 2.7 mM KCl, 25 mM Tris-Cl,
pH 8.0) supplemented with 0.1% Tween-20 overnight at 4uC.
Membranes were then incubated with anti-4-HNE (1:1000;
Abcam Inc, Cambridge, MA) or anti-nitrotyrosine (1:5000;
Millipore, Billerica, MA) in 5% BSA in TBST for 24 hours and
washed with TBST before incubation with anti-mouse IgG
secondary antibody (1:5000; GE Healthcare, Mississauga ON) in
5% BSA in TBST. Blots were developed using enhanced
chemiluminescence (ECL) (Millipore, Billerica, MA) and densito-
metric quantification was carried out using ImageJ software
(ImageJ, Version 1.37, NIH, Bethesda, MD, USA).
Measurement of 8-hydroxy-29-deoxyguanosine (8-OH-2-
dG) in urine
8-OH-2-dG, a marker of oxidative DNA damage, was
measured in urine samples from GD15 dams using a commer-
cially available EIA kit (Cayman Chemical, Ann Arbor, MI)
and normalized to urinary creatinine (Assay Designs, Ann Arbor,
MI).
Measurement of protein carbonyls in isolated
mitochondria
Protein carbonyls, a marker of oxidative damage to proteins
were measured in mitochondria isolated from whole placental
homogenates. Placental tissues were homogenized at a ratio of 1:5
with homogenization buffer (5 mM HEPES, pH 7.2, 100 mM
KCl, 70 mM sucrose, 220 mM mannitol, 1 mM EGTA, 2 mg/
mL fatty acid free BSA) plus protease inhibitor cocktail tablets
(Roche diagnostics, Indianapolis, IN) for 20 sec using a Polytron
homogenizer. These homogenates were rehomogenized manually
using a dounce homogenizer (Wheaton, Millville, NJ), and
centrifuged (Avanti J-301, Beckman Coulter, Fullerton, CA) at
12006g for 10 minutes at 4uC. The supernatant was centrifuged
at 12,0006g for 10 minutes at 4uC. The pellet was then washed in
1 mL of homogenization buffer without 2 mg/mL BSA, twice.
The final pellet was resuspended in 250 ml of homogenization
buffer without BSA [60].
Total protein carbonyl content in mitochondrially enriched
fractions prepared from GD15 placental homogenates was
determined using a commercially available kit (Oxyblot Protein
Oxidation Detection Kit, Chemicon International, Inc, Temecula,
CA, USA), according to the manufacturer’s instructions.
Statistical Evaluation
All statistical analysis was performed using GraphPad v4.0 for
Windows (GraphPad Software, San Diego, CA). Outcome
measures (continuous variables) between CON and HF groups
were compared using Student’s t-test (alpha=0.05) and categor-
ical variables were compared using Fisher’s exact test. Each dam
represents a single statistical unit. All data were tested for
normality and homogeneity of variance.
Supporting Information
Figure S1 Weight gain prior to pregnancy. Weight gain of
CON-fed (triangle) vs. HF–fed (black circle) dams prior to
pregnancy. Values represent mean 6 SEM; n$29.
(TIF)
Figure S2 Gestational blood pressure changes. Mean
arterial blood pressure changes were measured 7 days prior to
mating (indicated at gestation day 27) in CON-fed (open triangle)
vs. HF–fed (black circle) dams as well as at GD15 and GD20. The
initiation of gestation is indicated by the arrow. Blood pressure
values represent mean 6 SEM; n$17; *p,0.05.
(TIF)
Figure S3 Nitrotyrosine damage in the placenta of
obese dams is not significantly increased at GD15. A.
10 mg of whole placental homogenate was separated on a 12.5%
SDS-PAGE and subjected to Western blot analysis. The average
content of nitrotyrosine was normalized to total protein (using
Ponceau-S staining) in CON-fed and HF-fed dams. B. Represen-
tative lanes containing 10 mg placental homogenate developed
using an antibody directed towards nitrotyrosine. Values represent
mean 6 SEM; n=15 for CON and n=10 for HF-fed dams.
(TIF)
Table S1 Nutrient composition of rodent diets.
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